Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma
Condition: Urothelial Carcinoma (UC), Bladder (Urothelial, Transitional Cell) Cancer, Liquid Biopsy
Study Type: Observational
Clinical Trials Identifier NCT 8-digits: NCT07441499
Sponsor: Tianjin Medical University Second Hospital
Phase:
Eligibility:
- Age: minimum 18 Years maximum N/A
- Gender: All
Inclusion Criteria:
- Suspected or histologically confirmed urothelial carcinoma
Exclusion Criteria:
- History of or concurrent active malignancy other than urothelial carcinoma
View trial on ClinicalTrials.gov